Davis Jerel, Director at Repare Therapeutics Inc. (RPTX), sold 250,000 shares at $16.00 ($4.0M) on 2022-12-09, disclosed to the SEC on 2022-12-13.
Open-market sale of $4.0M RPTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| KDNY | SELL | 2023-03-03 | $12.7M | — | Filing → |
| RPTX | SELL | 2022-06-07 | $15.3M | — | Filing → |
| KDNY | SELL | 2022-01-05 | $16.0M | — | Filing → |